HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dorota Sulejczak Selected Research

neurotensin (8-13)

10/2016Neurotensin-based hybrid peptide's anti-inflammatory activity in murine model of a contact sensitivity response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dorota Sulejczak Research Topics

Disease

5Wounds and Injuries (Trauma)
11/2021 - 01/2011
3Inflammation (Inflammations)
11/2019 - 01/2014
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2018 - 01/2012
2Multiple Sclerosis
06/2021 - 12/2010
2Cicatrix (Scar)
04/2021 - 01/2017
2Asthma (Bronchial Asthma)
01/2021 - 11/2019
2Brain Injuries (Brain Injury)
05/2012 - 01/2009
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2011 - 12/2010
2Infarction (Infarctions)
11/2007 - 08/2007
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2021
1Nervous System Diseases (Neurological Disorders)
11/2021
1Substance-Related Disorders (Drug Abuse)
08/2021
1Graft vs Host Disease (Graft-Versus-Host Disease)
06/2021
1Infections
02/2021
1Respiratory Hypersensitivity
01/2021
1CADASIL
01/2017
1Hypersensitivity (Allergy)
10/2016
1Contact Dermatitis (Eczema, Contact)
10/2016
1Central Nervous System Diseases (CNS Diseases)
01/2016
1Gliosis
01/2014
1Asphyxia (Suffocation)
01/2014
1Hypoxia (Hypoxemia)
01/2014
1Ischemia
01/2014
1Fibrosis (Cirrhosis)
01/2013
1Seizures (Absence Seizure)
05/2012
1Spinal Muscular Atrophy (Progressive Muscular Atrophy)
01/2012
1Body Weight (Weight, Body)
02/2010
1Spinal Cord Injuries (Spinal Cord Injury)
12/2009
1Stroke (Strokes)
11/2007

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
02/2021 - 11/2007
3Keratins (Keratin)IBA
04/2021 - 01/2017
2Messenger RNA (mRNA)IBA
02/2021 - 12/2010
2Peptides (Polypeptides)IBA
11/2019 - 10/2016
2NeurotensinIBA
11/2019 - 10/2016
2endomorphin 2IBA
11/2019 - 10/2016
2HaptensIBA
11/2019 - 10/2016
2Glutamic Acid (Glutamate)FDA Link
01/2016 - 01/2014
2SMN Complex ProteinsIBA
01/2014 - 01/2012
2Brain-Derived Neurotrophic Factor (BDNF)IBA
12/2009 - 08/2007
1Pharmaceutical PreparationsIBA
08/2021
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2021
1Malondialdehyde (Propanedial)IBA
01/2021
1Peptide Hydrolases (Proteases)FDA Link
01/2021
1Phospholipases (Phospholipase)IBA
01/2021
1CytokinesIBA
01/2021
1mu Opioid Receptors (mu Opioid Receptor)IBA
01/2021
1Neurotensin Receptors (Neurotensin Receptor)IBA
01/2021
1PowdersIBA
01/2020
1SilverIBA
01/2020
1Biocompatible Materials (Biomaterials)IBA
01/2020
1Dexamethasone (Maxidex)FDA LinkGeneric
11/2019
1Cysteine (L-Cysteine)FDA Link
01/2017
1neurotensin (8-13)IBA
10/2016
1Opioid Analgesics (Opioids)IBA
10/2016
1DinitrofluorobenzeneIBA
10/2016
1lactide-caprolactone copolymerIBA
01/2014
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2014
1Dizocilpine Maleate (Dizocilpine)IBA
01/2014
1methylallyl trisulfide (MATS)IBA
01/2014
1Neuroprotective AgentsIBA
01/2014
1Memantine (Namenda)FDA Link
01/2014
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
05/2012
1Biomarkers (Surrogate Marker)IBA
05/2012
1Purinergic P2X7 ReceptorsIBA
01/2011
1Purinergic Receptors (Receptors, Purine)IBA
12/2010
1tempolIBA
02/2010
1IronIBA
02/2010
1Matrix Metalloproteinases (MMPs)IBA
01/2009

Therapy/Procedure

2Neurosurgical Procedures
01/2013 - 01/2011
1Investigational Therapies (Experimental Therapy)
11/2021
1Cell- and Tissue-Based Therapy (Cell Therapy)
11/2021
1Transplantation
06/2021
1Hematopoietic Stem Cell Transplantation
06/2021
1Craniotomy
01/2013